Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| Novo Nordisk A/S |
| Novartis AG |
| Orion Oyj |
| AstraZeneca PLC |
| Almirall, S.A. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| NOVO B | NOVN | ORNAV | AZN | ALM | HLUN B | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 88% | 33% | 39% | 20% | 2% | 14% | ||
| Fiscal Year - 1 | 88% | 16% | 24% | 16% | -3% | 11% | ||
| Fiscal Year - 2 | 72% | 10% | 42% | 9% | 0% | 10% | ||
| Fiscal Year - 3 | 71% | 37% | 26% | 0% | -3% | 7% | ||
| Fiscal Year - 4 | 70% | 14% | 29% | 22% | 6% | 9% | ||
| Fiscal Year - 5 | 71% | 11% | 26% | 10% | 9% | 15% | ||
| Average | 77% | 20% | 31% | 13% | 2% | 11% | ||
| Median | 72% | 15% | 28% | 13% | 1% | 10% | ||
| Benchmarks | Ticker | |||||||
| Novo Nordisk A/S | CPSE:NOVOB | |||||||
| Novartis AG | SWX:NOVN | |||||||
| Orion Oyj | HLSE:ORNAV | |||||||
| AstraZeneca PLC | OM:AZN | |||||||
| Almirall, S.A. | BME:ALM | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | NOVO B | NOVN | ORNAV | AZN | ALM | HLUN B | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 303,141 | 53,222 | 1,589 | 54,982 | 1,028 | 22,951 | ||
| Fiscal Year | 290,403 | 51,722 | 1,542 | 54,073 | 991 | 22,004 | ||
| Fiscal Year - 1 | 232,261 | 46,660 | 1,190 | 45,811 | 899 | 19,912 | ||
| Fiscal Year - 2 | 176,954 | 43,461 | 1,341 | 44,351 | 879 | 18,246 | ||
| Fiscal Year - 3 | 140,800 | 43,974 | 1,041 | 37,417 | 837 | 16,299 | ||
| Fiscal Year - 4 | 126,946 | 49,898 | 1,078 | 26,617 | 814 | 17,672 | ||
| Fiscal Year - 5 | 122,021 | 48,677 | 1,051 | 24,384 | 911 | 17,036 | ||
| Net Income | ||||||||
| Latest Twelve Months | 104,615 | 12,859 | 347 | 7,772 | 24 | 3,289 | ||
| Fiscal Year | 100,988 | 11,941 | 330 | 7,035 | 10 | 3,143 | ||
| Fiscal Year - 1 | 83,683 | 8,568 | 217 | 5,955 | (38) | 2,290 | ||
| Fiscal Year - 2 | 55,525 | 6,049 | 350 | 3,288 | 4 | 1,916 | ||
| Fiscal Year - 3 | 47,757 | 22,908 | 194 | 112 | (41) | 1,318 | ||
| Fiscal Year - 4 | 42,138 | 8,072 | 220 | 3,196 | 74 | 1,581 | ||
| Fiscal Year - 5 | 38,951 | 7,142 | 200 | 1,335 | 106 | 2,313 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 298,921 | 94,334 | 1,461 | 102,293 | 2,307 | 37,852 | ||
| Latest Fiscal Quarter | 489,162 | 99,941 | 1,702 | 106,253 | 2,396 | 54,219 | ||
| Fiscal Year | 465,795 | 102,246 | 1,629 | 104,035 | 2,397 | 56,976 | ||
| Fiscal Year - 1 | 314,486 | 99,945 | 1,439 | 101,119 | 2,375 | 37,407 | ||
| Fiscal Year - 2 | 241,257 | 117,453 | 1,504 | 96,483 | 2,148 | 37,452 | ||
| Fiscal Year - 3 | 194,508 | 131,795 | 1,114 | 105,363 | 2,142 | 34,653 | ||
| Fiscal Year - 4 | 144,922 | 127,778 | 1,116 | 66,729 | 2,291 | 36,029 | ||
| Fiscal Year - 5 | 125,612 | 118,370 | 1,036 | 61,377 | 2,440 | 38,133 | ||
| Fiscal Year - 6 | 110,769 | 145,563 | 1,147 | 60,651 | 2,390 | 23,011 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 98,911 | 39,675 | 708 | 37,445 | 1,476 | 22,435 | ||
| Latest Fiscal Quarter | 138,540 | 38,369 | 1,067 | 41,039 | 1,500 | 24,571 | ||
| Fiscal Year | 143,486 | 44,046 | 1,005 | 40,786 | 1,488 | 25,010 | ||
| Fiscal Year - 1 | 106,561 | 46,667 | 890 | 39,143 | 1,463 | 22,045 | ||
| Fiscal Year - 2 | 83,486 | 59,342 | 908 | 37,037 | 1,319 | 20,779 | ||
| Fiscal Year - 3 | 70,746 | 67,655 | 748 | 39,268 | 1,286 | 18,279 | ||
| Fiscal Year - 4 | 63,325 | 56,598 | 731 | 15,622 | 1,303 | 16,973 | ||
| Fiscal Year - 5 | 57,593 | 55,474 | 779 | 13,127 | 1,280 | 16,782 | ||
| Fiscal Year - 6 | 51,839 | 78,614 | 773 | 12,468 | 1,192 | 14,251 | ||